Psychiatry and Neurology, Neurology · Austin, TX
NPI
1710199724
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
12221 N Mopac Expy
Austin, TX, 78758
Phone (512) 901-4011
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
9,482 services
Medicare patients, 2024
373
Average age 73
Drug cost, 2024
$1.3M
3,848 prescriptions
Company payments, 2025
$794
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Greg Thaera was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,100 times for 12 patients. In total Greg Thaera billed 9,482 services in 57 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,100 | 12 | $4.84 | $39K |
| 99214 Office E&M - Established | Office | 501 | 293 | $99.64 | $50K |
| 99215 Office E&M - Established | Office | 145 | 83 | $148.31 | $22K |
| 36415 Venipuncture Blood Collection | Office | 73 | 58 | $8.65 | $631 |
| 86235 Immunoassay | Office | 72 | 18 | $17.57 | $1,265 |
| 99213 Office E&M - Established | Office | 70 | 62 | $60.11 | $4,208 |
| 85025 Blood Count | Office | 48 | 29 | $7.61 | $365 |
| 64615 Musculoskeletal | Office | 37 | 11 | $128.53 | $4,756 |
| 80053 Clinical Chemistry | Office | 22 | 22 | $10.19 | $224 |
| 84443 Clinical Chemistry | Office | 22 | 22 | $16.46 | $362 |
| 86780 Immunoassay | Office | 21 | 21 | $12.98 | $273 |
| 86225 Immunoassay | Office | 18 | 18 | $13.47 | $242 |
| 82746 Clinical Chemistry | Office | 15 | 15 | $14.41 | $216 |
| 84165 Clinical Chemistry | Office | 15 | 15 | $10.53 | $158 |
| 82607 Clinical Chemistry | Office | 14 | 14 | $14.78 | $207 |
By year: 2022 $110K for 7,687 services; 2023 $107K for 7,665 services; 2024 $128K for 9,482 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 73 | 58 | $8.65 | $631 |
| 86235 Immunoassay | 72 | 18 | $17.57 | $1,265 |
| 85025 Blood Count | 48 | 29 | $7.61 | $365 |
| 84443 Clinical Chemistry | 22 | 22 | $16.46 | $362 |
| 80053 Clinical Chemistry | 22 | 22 | $10.19 | $224 |
| 86780 Immunoassay | 21 | 21 | $12.98 | $273 |
| 86225 Immunoassay | 18 | 18 | $13.47 | $242 |
| 84165 Clinical Chemistry | 15 | 15 | $10.53 | $158 |
| 82746 Clinical Chemistry | 15 | 15 | $14.41 | $216 |
| 82607 Clinical Chemistry | 14 | 14 | $14.78 | $207 |
Medicare prescription drug claims, 2024
In 2024, the drug Greg Thaera prescribed most often to Medicare patients was Gabapentin, with 516 prescriptions and refills. In total Greg Thaera wrote 3,848 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 516 | 1,363 | 162 | $15K |
| Donepezil Hcl Generic | 214 | 576 | 71 | $2,703 |
| Levetiracetam Generic | 180 | 507 | 53 | $8,363 |
| Rizatriptan Rizatriptan Benzoate | 161 | 163 | 39 | $2,276 |
| Duloxetine Hcl Generic | 143 | 389 | 37 | $3,391 |
| Baclofen Generic | 129 | 377 | 39 | $7,346 |
| Lamotrigine Generic | 104 | 266 | 27 | $1,971 |
| Memantine Hcl Generic | 103 | 284 | 38 | $2,579 |
| Trazodone Hcl Generic | 90 | 256 | 27 | $1,220 |
| Tizanidine Hcl Generic | 87 | 206 | 30 | $1,173 |
| Topiramate Generic | 83 | 226 | 28 | $1,360 |
| Aimovig Autoinjector Erenumab-Aooe | 82 | 97 | 12 | $70K |
| Pregabalin Generic | 79 | 216 | 26 | $3,167 |
| Sertraline Hcl Generic | 64 | 168 | 21 | $927 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 63 | 157 | 20 | $1,759 |
Brand drugs: - claims; generic drugs: 3,502 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Greg Thaera $794 ($794 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $175.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $175 |
| Biogen, Inc. BIIB | 4 | $100 |
| UCB, Inc. UCB.BR | 3 | $90.44 |
| Genentech USA, Inc. ROG.SW | 3 | $72.38 |
| Pfizer Inc. PFE | 3 | $50.61 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $50.13 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $47.9 |
| TG Therapeutics, Inc. TGTX | 2 | $45.02 |
| Abbott Laboratories ABT | 2 | $44.16 |
| Argenx US, Inc. ARGX | 2 | $33.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.